FHI Stock Cash Flow Statements

Federated Hermes . Quarterly Cash Flow Statements Chart

Quarterly

Annual

Federated Hermes . Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-09-30	2013-06-30	2013-03-31	2012-09-30	2012-06-30	2012-03-31	2011-09-30	2011-06-30	2011-03-31	2010-09-30	2010-06-30	2010-03-31	2009-09-30	2009-06-30	2009-03-31	2008-09-30	2008-06-30	2008-03-31	2007-09-30	2007-06-30	2007-03-31	2006-09-30

operating activities
net income including the noncontrolling interests in subsidiaries	96,691,000	103,876,000	83,854,000	90,341,000	19,225,000	75,010,000	86,047,000	74,266,000	73,002,000	71,466,000	61,635,000	67,574,000	50,758,000	54,597,000	70,997,000	73,486,000	53,479,000	74,346,000	101,272,000	86,684,000	84,801,000	63,265,000	85,089,000	73,585,000	63,840,000	54,611,000	61,632,000	61,994,000	38,667,000	60,006,000	131,974,000	57,241,000	54,659,000	51,027,000	57,229,000	58,908,000	56,603,000	48,774,000	49,169,000	44,136,000	42,263,000	36,418,000	39,604,000	37,259,000	37,314,000	35,645,000
adjustments to reconcile net income to net cash provided (used) by operating activities
depreciation and amortization	5,637,000	5,416,000	5,556,000	5,714,000	5,534,000	5,625,000		6,093,000	6,702,000	8,022,000		6,774,000	6,961,000	7,462,000
share-based compensation expense	6,392,000	11,117,000	6,043,000	6,170,000	6,302,000	10,269,000	6,782,000	7,488,000	8,997,000	10,680,000	7,179,000	8,899,000	9,432,000	9,288,000	7,011,000	6,307,000	7,760,000	9,216,000	6,445,000	6,289,000	6,468,000	7,467,000	5,909,000	5,960,000	6,078,000	7,110,000	5,649,000	5,476,000	5,801,000	6,967,000	5,218,000	5,056,000	5,562,000	6,672,000	5,233,000	4,285,000	5,691,000	7,236,000	5,330,000	5,003,000	5,451,000	6,901,000	5,091,000	4,773,000	5,530,000	6,317,000	4,864,000	5,044,000	5,714,000	4,577,000	4,799,000	5,583,000	4,387,000	4,619,000	5,458,000	4,081,000	4,997,000	5,625,000	4,212,000	4,295,000	5,730,000	4,462,000	3,612,000	3,653,000	2,987,000	3,240,000	3,021,000
(gain) loss on disposal of assets	-1,702,000	-1,530,000	-327,000	-1,468,000	521,000	-278,000	417,000	244,000	-882,000	481,000	858,000	4,723,000	-587,000	-150,000	11,000	-1,812,000	-3,479,000	-1,684,000	-208,000	418,000	1,072,000	100,000		-680,000	199,000	492,000																												-156,000	-2,454,000
benefit for deferred income taxes	-1,380,000	531,000	-3,779,000	-6,525,000	-7,281,000	2,650,000	8,236,000	-2,608,000	-1,300,000	-76,000	-11,749,000	-4,806,000	-4,505,000	2,342,000	-462,000	817,000	15,081,000	3,597,000	6,262,000	5,270,000	3,891,000	2,746,000	1,496,000	618,000	642,000	4,696,000																														3,124,000	9,933,000	946,000	-2,736,000	2,146,000	-9,203,000	916,000			-1,023,000	-1,398,000	428,000
consolidation/(deconsolidation) of other entities	0	0		443,000	-3,168,000	409,000		5,666,000	0	-2,176,000		0	0	-20,000		-650,000	-760,000	11,789,000
net unrealized (gain) loss on investments	-9,511,000	568,000	3,537,000	-6,468,000	336,000	-1,334,000	-11,503,000	3,198,000	856,000	-5,974,000	-11,042,000	2,110,000	21,468,000	11,847,000	-1,992,000	2,469,000	-2,764,000	322,000	-14,006,000	-6,267,000	-14,878,000	15,748,000			-764,000	-2,162,000
net sales (purchases) of investments—consolidated investment companies	-68,303,000	-15,141,000	-6,300,000	-13,307,000	-10,221,000	1,257,000	1,983,000	-18,468,000	-9,460,000	-8,383,000	6,046,000	17,003,000	-12,282,000	-30,937,000	-49,772,000	-65,248,000	-13,272,000	-51,127,000	-5,462,000	-11,791,000	783,000	3,492,000
impairment of intangible asset			0	0
other changes in assets and liabilities:
increase in receivables	5,448,000	-10,955,000	8,733,000	1,223,000	4,414,000	2,978,000	3,413,000	9,655,000	-25,404,000	-15,232,000	-8,904,000	4,527,000	-9,833,000	9,843,000	2,748,000	-3,019,000	191,000	6,742,000	5,656,000			8,687,000		-5,503,000	6,504,000	-575,000																																-2,357,000							-838,000	-803,000	-1,060,000
increase in prepaid expenses and other assets	-5,028,000	1,280,000	5,693,000	7,881,000	-1,624,000	7,921,000	1,359,000	2,407,000	15,658,000	1,324,000	42,316,000	-20,208,000	-634,000	-2,892,000	6,388,000	6,391,000	838,000	-3,342,000	-24,271,000						-4,809,000	2,693,000																																	5,025,000			3,871,000
increase in accounts payable and accrued expenses	22,157,000	-101,218,000	37,399,000	34,806,000	30,885,000	-93,731,000	38,569,000	22,326,000	15,353,000	-61,621,000	27,653,000	30,024,000	35,198,000	-88,206,000	30,404,000	30,954,000	33,893,000	-101,616,000	28,106,000						29,339,000	-72,337,000																																										14,562,000
increase in other liabilities	-31,614,000	20,355,000	-8,017,000	-1,661,000	-22,580,000	3,255,000	-9,846,000	-4,632,000	-12,378,000	6,909,000	-19,987,000	-4,601,000	2,787,000	6,872,000	-5,132,000	-13,887,000	-16,046,000	11,789,000	16,106,000	-38,526,000	21,264,000	10,108,000			-8,796,000	6,281,000	1,080,000	5,516,000	-9,094,000	11,070,000	731,000	2,664,000	-20,797,000	22,187,000				12,780,000	2,617,000	2,307,000	-6,755,000	9,628,000	2,884,000	2,816,000	-9,191,000	9,741,000	-735,000	-2,230,000	3,957,000			4,735,000	-51,000	738,000	9,069,000	311,000			2,898,000	1,851,000	-242,000	-247,000	1,966,000	2,554,000	2,695,000	761,000	2,401,000
net cash provided (used) by operating activities	18,787,000	14,299,000	126,700,000	117,149,000	88,674,000	14,031,000	129,632,000	105,635,000	71,144,000	5,420,000	132,413,000	112,019,000	98,763,000	-19,247,000	69,427,000	46,005,000	84,964,000	-30,013,000	129,783,000	90,061,000	124,146,000	29,251,000	122,599,000	99,918,000	95,665,000	16,758,000
investing activities
purchases of investments—affiliates and other	-980,000	-1,758,000	-2,458,000	-16,447,000	-2,893,000	-25,718,000	-44,399,000	-2,355,000	-9,662,000	-1,583,000	-4,038,000	-13,525,000	-3,073,000	-2,008,000	-2,208,000	-1,578,000	-3,832,000	-1,811,000	-6,463,000						-13,796,000	-1,566,000
cash paid for business acquisitions, net of cash acquired											-28,111,000				5,324,000	-5,324,000	0	0	0	0			0	0
proceeds from redemptions of investments—affiliates and other	4,505,000	1,230,000	44,362,000	9,207,000	12,448,000	53,874,000	7,337,000	5,754,000	18,053,000	4,160,000	1,381,000	13,322,000	6,746,000	1,321,000	2,699,000	19,376,000	11,449,000	2,466,000	5,078,000	2,510,000	1,713,000	2,192,000	48,429,000	30,728,000	726,000	1,185,000	297,000	17,567,000	847,000	1,572,000
cash paid for property and equipment	-786,000	-972,000	-505,000	3,028,000	-5,978,000	-569,000	-2,112,000	-2,081,000	-2,983,000	-739,000	-278,000	-1,205,000	-1,036,000	-1,853,000	-2,668,000	-4,498,000	-1,096,000	-2,159,000	-4,941,000						-3,804,000	-5,060,000																											-1,433,000	-3,530,000	-1,857,000	-1,560,000	-2,437,000	-1,129,000	-2,296,000
other investing activities	-6,000,000	-28,000	0
net cash provided (used) by investing activities	-16,016,000	-1,528,000	41,399,000	-8,312,000	3,577,000	27,587,000	-39,174,000	1,318,000	5,408,000	1,838,000	-31,046,000	-1,408,000	2,637,000	-2,540,000	-2,177,000	7,976,000	6,521,000	-1,504,000	-6,326,000						-16,089,000	-5,441,000					109,996,000	-162,000	2,821,000	5,314,000																-18,452,000	19,999,000	9,659,000												8,800,000
financing activities
dividends paid	-26,846,000	-25,305,000	-25,223,000	-25,573,000	-110,281,000	-23,734,000	-24,130,000	-24,703,000	-25,111,000	-24,149,000	-24,111,000	-24,145,000	-24,706,000	-24,953,000	-26,096,000	-26,329,000	-26,551,000	-26,788,000	-126,153,000						-27,332,000	-27,217,000																											-25,019,000	-25,092,000	-24,950,000	-24,727,000	-24,770,000	-154,454,000	-24,679,000	-24,680,000	-24,553,000	-305,396,000	-24,450,000	-21,371,000	-21,481,000	-21,610,000	-18,675,000	-18,938,000
purchases of treasury stock	-65,524,000	-120,131,000	-23,446,000	-28,901,000	-46,242,000	-39,026,000	-65,053,000	-64,098,000	-41,353,000	-6,562,000	-6,925,000	-6,612,000	-91,266,000	-113,338,000	-135,923,000	-14,453,000	-38,900,000	-39,073,000	-13,614,000						-709,000	-1,485,000																											-8,764,000	-7,426,000	-3,677,000	-3,169,000	-5,562,000	-558,000	-12,464,000	-5,499,000	-843,000	-844,000	-37,245,000	-2,042,000	-61,155,000	-10,506,000	-42,983,000	-32,180,000
distributions to noncontrolling interests in subsidiaries	-13,536,000	-8,367,000	-12,851,000	-10,567,000	-4,430,000	-3,410,000	-7,393,000	-14,889,000	-14,454,000	-3,224,000	-3,835,000	-16,620,000	-1,185,000	-4,339,000																																							18,000	-9,000	-1,530,000
contributions from noncontrolling interests in subsidiaries	74,205,000	16,235,000	36,614,000	13,503,000	16,303,000	2,724,000	5,040,000	35,323,000	19,684,000	12,776,000	5,023,000	4,494,000	15,314,000	30,340,000																																							0	568,000	5,943,000
other financing activities	8,000	0	1,340,000	1,000	0	38,000	1,259,000	15,000	0	0	-5,728,000	6,913,000	15,000	-9,499,000	1,416,000	30,000	30,000	-2,008,000	-218,000						171,000	0													0	0	0	0																				44,000	-22,000	-22,000	-21,000	-21,000	-94,000	-78,000
net cash provided (used) by financing activities	-31,693,000	-137,568,000	-26,273,000	-51,549,000	-145,049,000	-63,526,000	-91,485,000	-68,352,000	-61,234,000	-22,016,000	-78,523,000	-43,023,000	-101,828,000	54,861,000	-36,089,000	-101,573,000	-62,820,000	-48,990,000	-153,322,000			50,400,000			-31,590,000	-35,919,000																														-40,959,000
effect of exchange rates on cash, cash equivalents, restricted cash and restricted cash equivalents	12,356,000	5,266,000		10,416,000	75,000	-1,412,000		-4,531,000	3,604,000	2,047,000		-12,263,000	-13,212,000	-4,505,000		-4,584,000	556,000	1,270,000							-2,510,000	2,264,000
net increase in cash, cash equivalents, restricted cash and restricted cash equivalents	-16,566,000	-119,531,000	128,952,000	67,704,000	-52,723,000	-23,320,000	5,718,000	34,070,000	18,922,000	-12,711,000	32,650,000	55,325,000	-13,640,000	28,569,000	31,608,000	-52,176,000	29,221,000	-79,237,000	-20,615,000	45,251,000	-30,520,000	65,008,000	50,999,000	17,948,000	45,476,000	-22,338,000			49,539,000	9,407,000
cash, cash equivalents, restricted cash and restricted cash equivalents, beginning of period	0	507,567,000	0	0	0	386,954,000	0	0	0	340,955,000	-1,000	0	0	238,052,000	0	0	0	308,635,000	0	0	0	249,511,000	0	0	0	157,426,000	0	0	0	316,809,000
cash, cash equivalents, restricted cash and restricted cash equivalents, end of period	-16,566,000	388,036,000	128,952,000	67,704,000	-52,723,000	363,634,000	5,718,000	34,070,000	18,922,000	328,244,000	32,649,000	55,325,000	-13,640,000	266,621,000	31,608,000	-52,176,000	29,221,000	229,398,000	-20,615,000	45,251,000	-30,520,000	314,519,000	50,999,000	17,948,000	45,476,000	135,088,000	39,903,000	-258,232,000	49,539,000	326,216,000
less: restricted cash recorded in other current assets	0	0	-529,000	187,000	-369,000	3,374,000	-388,000	-128,000	147,000	3,867,000	257,000	-462,000	-311,000	4,289,000	-30,000	-149,000	-1,909,000	6,507,000	364,000	242,000	-14,000	5,863,000
less: restricted cash and restricted cash equivalents recorded in other long-term assets	14,000	469,000	-8,000	-2,000	-5,000	478,000	-114,000	-5,000	1,000	394,000	130,000	-1,000	-18,000	289,000	3,000	13,000	3,000	286,000	49,000	2,000	3,000	307,000	9,000	-275,000	0	603,000	14,000	-3,000	-24,000	607,000
cash and cash equivalents	-16,580,000	387,567,000	129,489,000	67,519,000	-52,349,000	359,782,000	6,220,000	34,203,000	18,774,000	323,983,000	32,262,000	55,788,000	-13,311,000	262,043,000	31,635,000	-52,040,000	31,127,000	222,605,000	-21,028,000	45,007,000	-30,509,000	308,349,000	52,661,000	16,552,000	45,476,000	134,485,000	39,889,000	-258,229,000	49,563,000	325,609,000
cash paid for business acquisitions		0	-2,707,000	-12,000	-399,000	-118,000	-1,208,000	0	0	-857,000																			0	0										0	0	0											-2,700,000	-543,000	-44,732,000	-8,195,000	-32,775,000	-5,157,000	-3,152,000	-20,165,000	-762,000			0			-8,383,000
adjustments to reconcile net income to net cash from operating activities
subsidiary share-based compensation expense							0	0	0	0	0	0	0	707,000	1,855,000	2,557,000	2,517,000	2,482,000	2,382,000	2,164,000	2,087,000	2,153,000	1,864,000	2,125,000
consolidation/(deconsolidation) of investment companies																			0
proceeds from new borrowings							0	0	0	0	0	0	0	488,300,000	213,500,000	82,150,000	0	0	0	0	0	100,000,000	0	0	0	8,800,000	8,500,000	61,150,000
payments on debt							0	0	0	0	-50,000,000	0	0	-311,650,000	-92,300,000	-45,000,000	-5,000,000	-5,000,000	-15,000,000						-5,000,000	-13,800,000
effect of exchange rates on cash, cash equivalents, restricted cash, and restricted cash equivalents
supplemental disclosure of cash flow information
cash paid during the year for:
income taxes
interest
depreciation and other amortization																	7,329,000	7,236,000	7,222,000	7,253,000	7,181,000	6,907,000	6,757,000	6,714,000	5,230,000	7,221,000	6,320,000	5,424,000	2,705,000	2,638,000	2,849,000	2,609,000	2,595,000	2,584,000	2,480,000	2,239,000	2,508,000	2,351,000	2,351,000	2,333,000	2,344,000	2,507,000	2,693,000	2,581,000	2,686,000	2,744,000	2,701,000	2,503,000	2,492,000	2,570,000	2,543,000	2,767,000	3,212,000	3,486,000	4,603,000	5,126,000	5,478,000	5,470,000	5,730,000	5,667,000	6,550,000	5,954,000	6,062,000	6,100,000	6,600,000	5,622,000	6,907,000	6,878,000
cash paid for asset acquisitions
payments to acquire additional equity in fhl											0
notes to the consolidated financial statements
payments to acquire additional equity in hfml															-2,190,000
distributions to noncontrolling interest in subsidiaries																-1,178,000	-1,016,000	-1,898,000							-541,000	-2,260,000																														-2,705,000	-4,484,000	-2,481,000	-2,442,000	-2,589,000	-2,122,000
contributions from noncontrolling interest in subsidiaries																66,903,000	8,632,000	25,762,000		3,212,000	6,225,000	5,577,000		687,000	1,821,000	43,000		3,262,000	663,000	500,000		596,000	681,000	2,818,000		3,266,000	5,343,000	5,431,000		5,670,000	4,754,000	5,785,000		7,875,000	1,168,000	2,049,000	11,397,000	4,815,000	5,024,000	631,000	12,752,000	347,000				2,061,000	2,010,000	3,396,000	4,348,000	164,000	2,174,000
amortization of deferred sales commissions																	197,000	237,000	279,000	320,000	362,000	408,000	452,000	495,000	538,000	592,000	648,000	705,000	775,000	839,000	1,445,000	1,701,000	2,271,000	2,608,000	3,001,000	3,123,000	2,952,000	2,904,000	3,280,000	3,716,000	4,040,000	4,018,000	3,784,000	3,339,000	2,937,000	2,639,000	2,330,000	2,274,000	2,113,000	1,961,000	1,790,000	1,625,000	1,337,000	1,880,000	2,782,000	2,988,000	3,114,000	3,172,000	5,104,000	4,959,000	4,873,000	7,761,000	8,801,000	9,361,000	11,299,000	12,074,000	12,258,000	12,600,000
proceeds from shareholders for share-based compensation																		15,000					1,238,000			0	1,222,000	15,000	106,000	101,000	1,209,000	0			1,214,000	73,000	149,000	0	1,453,000	17,000	1,000	81,000	1,469,000	97,000	0	480,000	45,000			0	9,000	0	0	1,236,000	13,917,000	196,000	0	487,000	459,000	3,317,000	921,000	16,394,000
consolidation/deconsolidation of investment companies																															0
payments on contingent consideration liabilities
loss on derivative
net sales of investments—consolidated investment companies																									-6,235,000	8,136,000	7,394,000	1,559,000	7,243,000	500,000
net unrealized gain on investments																											2,521,000	-748,000	644,000	1,905,000
adoption of new accounting pronouncement																															0	0	0	0
deferred sales commissions paid																																																					-2,283,000	-2,228,000	-2,254,000	-2,633,000	-2,666,000	-2,796,000	-3,269,000	-3,097,000	-2,378,000	-2,282,000	-3,503,000	-3,611,000	-1,608,000	-1,745,000	-5,229,000	-5,667,000
contingent deferred sales charges received																											0	0			301,000	327,000	545,000	612,000	559,000	543,000	515,000	578,000	524,000	694,000	583,000	549,000	486,000	419,000	302,000	585,000	625,000	358,000	425,000	297,000	400,000	352,000	330,000	355,000	506,000	484,000	592,000	685,000	709,000	863,000	1,164,000	1,718,000	1,883,000	2,407,000	2,883,000	3,094,000	3,323,000	3,778,000
distributions from equity investments
net cash from operating activities																											119,912,000	-50,016,000	88,290,000	48,096,000	79,654,000	91,795,000	65,904,000	33,024,000	77,253,000	86,366,000	63,507,000	25,645,000	80,961,000	79,643,000	57,917,000	14,663,000	80,792,000	46,452,000	47,488,000	17,750,000	54,728,000	47,706,000	19,773,000	156,603,000	53,034,000	30,256,000	70,810,000	27,662,000	46,500,000	71,259,000	66,313,000	33,419,000	88,076,000	56,942,000	55,714,000	78,920,000	60,167,000	75,611,000	93,062,000	63,207,000	71,856,000	74,565,000
capex																											0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-5,740,000	-2,162,000	-2,104,000	-2,230,000	-1,357,000	-816,000	-1,350,000	-907,000
free cash flows																											119,912,000	-50,016,000	88,290,000	48,096,000	79,654,000	91,795,000	65,904,000	33,024,000	77,253,000	86,366,000	63,507,000	25,645,000	80,961,000	79,643,000	57,917,000	14,663,000	80,792,000	46,452,000	47,488,000	17,750,000	54,728,000	47,706,000	19,773,000	156,603,000	53,034,000	30,256,000	70,810,000	27,662,000	46,500,000	71,259,000	66,313,000	33,419,000	88,076,000	56,942,000	49,974,000	76,758,000	58,063,000	73,381,000	91,705,000	62,391,000	70,506,000	73,658,000
distribution from equity investment
net cash (used) provided by investing activities
net cash used by financing activities																																																							-22,057,000							-136,379,000	-70,821,000	-34,308,000	-90,372,000	-44,290,000	-69,475,000	-50,602,000
gain on disposal of assets																																							1,217,000	1,436,000	209,000	551,000																	-40,000	-35,000	456,000		44,000	-216,000	4,797,000	-99,000	-21,000
benefit from deferred income taxes																												2,203,000	1,292,000	4,318,000		1,105,000	1,341,000	5,780,000	3,810,000	1,775,000	2,641,000	9,270,000	6,228,000	1,459,000	3,161,000	8,415,000	6,764,000	3,330,000	3,865,000	7,655,000	2,573,000	3,180,000	10,132,000	8,310,000	3,082,000	10,716,000	3,724,000	5,675,000	4,071,000									808,000				-634,000
fair-value adjustments for contingent liabilities																												-27,000							320,000				38,000							0							0	0	900,000
decrease in accounts payable and accrued expenses																																																					9,949,000	-7,396,000	-19,515,000	11,668,000	17,256,000	-46,127,000	6,961,000	8,699,000	-31,597,000		14,774,000	-35,518,000		14,445,000	-20,779,000
cash paid for amended and restated credit agreement																												0
decrease in receivables																													5,347,000	3,424,000																													3,839,000	4,453,000	554,000
decrease in prepaid expenses and other assets																														861,000										4,970,000	-424,000	1,574,000				2,801,000			7,017,000			4,501,000			6,619,000			20,333,000			3,523,000			8,911,000
impairment of assets																															0	0			0	0			0				0										0			0	6,956,000	0	1,000,000	0	20,163,000
net sales (purchases) of trading securities																															2,322,000	1,123,000	11,063,000	2,516,000												130,000
purchases of securities available for sale																																																					-60,712,000	-699,000	-10,697,000	-7,439,000	-50,341,000	-422,000	-6,000	-5,000	-1,272,000	-4,000	-3,000	-4,000	-104,000	-1,005,000	-1,003,000	-106,000
proceeds from redemptions of securities available for sale																															113,867,000	9,033,000	4,899,000	12,450,000	10,000	7,829,000	101,000	50,000	5,755,000	1,000	0	0	0	45,424,000	32,322,000	9,371,000	32,559,000	44,052,000	11,758,000	6,405,000	51,594,000	17,949,000	15,884,000	-1,000	10,912,000	45,065,000	232,000	105,000	1,000	-1,000	1,000	0	1,000	11,034,000	0	1,000	996,000	5,818,000
excess tax benefits from share-based compensation																																			0	0	-596,000	596,000	1,103,000	343,000	542,000	1,656,000	954,000	344,000	361,000	1,007,000	331,000	317,000	463,000	283,000	299,000	463,000	-241,000	-286,000	-920,000	-259,000	-288,000	-2,155,000	-272,000	-477,000	-205,000	-5,485,000	-443,000	-706,000	-1,782,000	-1,745,000	-1,494,000
net increase in cash and cash equivalents																															154,854,000	46,242,000							31,471,000								-9,132,000			98,237,000	33,722,000	2,252,000	-22,452,000			16,742,000	164,369,000	-48,879,000	17,877,000	-8,497,000	6,183,000		-29,426,000	50,103,000			-7,330,000
cash and cash equivalents, beginning of year
cash and cash equivalents, end of year
decrease (increase) in prepaid expenses and other assets
cash and cash equivalents, beginning of period																																0	0	104,839,000		0	0	172,628,000		0	0	115,267,000		0	0	104,443,000	0	0	67,585,000	0	0	49,273,000	0	0	198,756,000	0	0	90,452,000	0	0	45,438,000	0	0	120,350,000	0	0	118,721,000	0
cash and cash equivalents, end of period																																46,242,000	20,539,000	94,629,000		31,244,000	6,098,000	147,762,000		32,070,000	17,254,000	91,833,000		29,384,000	-10,494,000	71,575,000	-9,132,000	30,967,000	56,427,000	98,237,000	33,722,000	51,525,000	-22,452,000	-21,577,000	176,825,000	16,742,000	164,369,000	41,573,000	17,877,000	-8,497,000	51,621,000	-96,146,000	-29,426,000	170,453,000	-48,404,000	-5,924,000	111,391,000	-73,286,000
decrease (increase) in receivables																																	1,128,000	98,000									669,000	-195,000	681,000	666,000									916,000							1,166,000	1,755,000	360,000				-1,175,000
net decrease in cash and cash equivalents																																																							-21,931,000										-48,404,000
net purchases of trading securities																																																					-109,000	-1,227,000	-6,487,000	-639,000	-35,000	-2,774,000	-3,465,000	-439,000	-4,889,000	-2,230,000	-1,506,000	-651,000	-823,000			-68,000
net cash used by investing activities																																																					-48,961,000	-4,773,000	-46,374,000	-13,558,000						-38,687,000			-51,094,000	-24,841,000	-9,711,000	-97,249,000
loss on disposal of assets																																				23,000	220,000	1,174,000																			-193,000	492,000
net (purchases) sales of trading securities																																																																			-6,257,000
cash paid for contingent liabilities
tax benefit from share-based compensation																																														983,000							56,000	-145,000	217,000							7,284,000	447,000	746,000	1,758,000	2,092,000	2,146,000
net income including noncontrolling interests in subsidiaries																																															37,630,000	41,861,000	44,688,000							48,063,000	48,275,000	44,195,000	60,286,000
tax benefit (detriment) from share-based compensation																																																	173,000							143,000	-211,000	1,604,000
net cash from investing activities																																																20,252,000	4,451,000									-3,305,000	-5,453,000	-22,099,000	-7,773,000
net income including noncontrolling interest in subsidiaries																																																		58,193,000	43,073,000	44,407,000	38,521,000	42,884,000	35,054,000
tax (detriment) benefit from share-based compensation																																																											133,000	560,000	-1,037,000
payments on debt—recourse
payments on debt—nonrecourse
proceeds from sale of certain b-share-related future revenue																																																					0	0	0	2,000	31,000	1,190,000	1,363,000	1,452,000	1,107,000	1,278,000	1,849,000	1,810,000
increase in income taxes payable																																																					-96,000	-6,270,000	7,935,000	533,000	-5,804,000	6,350,000	598,000	-22,795,000	23,676,000	-322,000	-21,235,000	22,398,000	796,000	-21,830,000	22,670,000	-23,000
cash paid for purchased loans																																																					0			-41,429,000
proceeds from disposal of property and equipment																																																					0	0	0	0	0	3,298,000
proceeds from new borrowings – recourse																																																					0	0	0	0	309,500,000	97,500,000	0	26,500,000	28,300,000
proceeds from new borrowings – nonrecourse																																																					0	0	0	0	10,000	261,000	299,000	319,000	243,000	281,000	406,000	397,000	379,000	220,000	3,206,000	3,969,000
payments on debt – recourse																																																					-10,625,000	-10,625,000	-10,625,000	-10,625,000	-85,250,000	-22,750,000	-25,524,000	-36,324,000	-40,523,000
payments on debt – nonrecourse																																																					-152,000	-1,568,000	-2,055,000	-2,249,000	-2,585,000	-2,549,000	-5,015,000	-5,025,000	-5,560,000	-8,991,000	-9,911,000	-11,033,000	-13,627,000	-13,672,000	-14,010,000	-14,974,000
net cash (used) provided by financing activities																																																					-44,301,000
other																																																								0
decrease in other liabilities																																																										-434,000
net cash from financing activities																																																										-78,993,000	-64,746,000	-43,340,000	-41,758,000
adjustments to reconcile net income including noncontrolling interests in subsidiaries to net cash from operating activities
proceeds from disposal of business
net income																																																													37,469,000	56,212,000	58,024,000	55,819,000	57,728,000	55,277,000	51,763,000	45,609,000
adjustments to reconcile net income attributable to federated investors, inc. to net cash from operating activities
additions to property and equipment																																																													-5,740,000	-2,162,000	-2,104,000	-2,230,000	-1,357,000	-816,000	-1,350,000	-907,000
minority interest																																																														2,455,000	2,020,000	1,386,000	1,469,000	1,400,000	1,376,000	1,359,000
(gain) loss on disposal of business and assets
cash paid for business acquisitions and minority interest investments																																																														-41,321,000			-49,633,000
decrease in restricted cash equivalents																																																														0	0	0	0	0	29,000
distributions to minority interest																																																														-3,391,000	-1,171,000	-1,342,000	-1,342,000	-2,042,000	-869,000	-1,298,000
contributions from minority interest																																																														105,000	73,000	60,000	906,000	587,000	1,722,000	0
proceeds from shareholders for share-based compensation and other																																																																339,000	4,187,000	1,009,000	734,000
increase in other assets																																																																	-8,815,000			-9,069,000
net proceeds from disposal of business, equipment and other assets																																																																				273,000
adjustments to reconcile net income to net cash from operating activities:
net proceeds from disposal of business																																																																		0	0
decrease (increase) in other assets																																																																			403,000
stock-based compensation expense																																																																				2,759,000
tax benefit from stock-based compensation																																																																				9,425,000
excess tax benefits from stock-based compensation																																																																				-9,051,000
increase in other current liabilities																																																																				3,872,000
increase in other long-term liabilities																																																																				240,000
decrease (increase) in restricted cash equivalents
proceeds from shareholders for stock-based compensation and other
proceeds from shareholders for stock-based compensation

We provide you with 20 years of cash flow statements for Federated Hermes . stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Federated Hermes . stock. Explore the full financial landscape of Federated Hermes . stock with our expertly curated income statements.

The information provided in this report about Federated Hermes . stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.